Top 5 Medical VC (Venture Capital) Funds in Argentina in May 2026
Top 5 Medical VC (Venture Capital) Funds in Argentina in May 2026
| Investor | Medical Argentina investments |
|---|---|
| Zentynel Frontier Investments | 1 |
| Sonen Capital | 1 |
| Sky High VC | 1 |
| Oncology Ventures | 1 |
| LabCorp Venture Fund | 1 |
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!
Zentynel Frontier is a investment firm.
Show more...Investment focus
- Health Care, Baby, Fitness
- Series A, Seed, Angel
- United States, Sweden
Portfolio highlights
- Asclepii — Multi-dimensional Wound Healing | Cell therapy is the future of human health. | Regenerative medicine for modern wound care.
- BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
- MultiplAI Health — Universal genomic screening for virtually any complex diseases, including cardiovascular disorders and cancer.
Sonen Capital is a dedicated impact investment management firm. Their name is derived from Social and Environmental investing and reflects their values and their conviction that investing to generate financial returns and lasting social and environmental impact are not only compatible but also mutually reinforcing objectives.With over fivedecades of combined sustainable investing learning and experience, Sonen team members are field builders dedicated to helping mobilize financial assets to help meet large-scale global challenges. This deep experience serves not only to inform and improve Their knowledge and understanding of this evolving area, but it also enhances. Their ability to deliver to their clients increasingly more sophisticated and holistic impact investing solutions.
Show more...Portfolio highlights
- BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
Discover Sky High VC: Fueling the future with a fund for visionary entrepreneurs. Join us to shape the new economy through science and technology.
Show more...Investment focus
- Medical, Biopharma, Therapeutics
- Series A
- Argentina
Portfolio highlights
- BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
Oncology Ventures will make investments in cancer-focused data, infrastructure, IT, and services start-ups with the goal of fundamentally changing the way cancer treatment is conceived and provided at scale. Our fund will not invest in pharmaceuticals, therapies, or medical devices.
Show more...Investment focus
- Internet, Health Care, Information Technology
- Series A
- United States
Portfolio highlights
- WellBeam — WellBeam provides an EMR-integrated solution to digitize and streamline acute provider ability to follow and manage a patient's post-acute status and care. WellBeam enables MDs & APPs to sign orders electronically, to respond quickly to secure instant messages from home health clinicians about change of patient condition (including access to wound images), and to bill new CMS G-codes - all from within Epic or their EMRs ecosystem.
- BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
- RISA Labs — AI-powered operating system for oncology. Automate workflows, reduce treatment delays, and accelerate care delivery. Book a demo with RISA Labs.
LabCorp Venture Fund invests in early stage private companies operating in current or strategically adjacent spaces and developing novel solutions to important problems in health and healthcare.Investments are typically early stage (Series A or Series B). LabCorp’s typical initial investment is $500K-$2M, reserving up to $5M for follow-oninvestment. LabCorp typically does not lead financing rounds, but prefers to co-invest with an institutional or strategic lead.
Show more...Investment focus
- Health Care, Biotechnology, Health Diagnostics
- Funding Round, Seed, Series B
- United States, Switzerland
Portfolio highlights
- AOA — AOA based in Boston, New York, and London developing cancer diagnostics in the field of women’s health.AOA is a female-led company, is committed to bringing the first accurate early-stage liquid biopsy ovarian cancer diagnostic test to market that will improve clinical practice, help reduce patient mortality and deliver cost savings to payers.
- Prenosis — Prenosis Inc. is a health tech innovator devoted to ushering in a new era of precision diagnostics in acute care using artificial intelligence. Its ImmunixTM precision diagnostics platform leverages machine learning algorithms trained on deep biological data and broad clinical data to more holistically capture and illuminate the complex healthstates of patients. Its proprietary NOSISTM dataset is the largest and fastest growing hybrid biomarker-clinical dataset for sepsis care. The Sepsis ImmunoScoreTM diagnostic on the ImmunixTM platform has the potential to save thousands of lives and billions of dollars in healthcare spending annually.
- BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!
